Skip to main content
Top
Published in: La radiologia medica 10/2019

01-10-2019 | Hepatocellular Carcinoma | VASCULAR AND INTERVENTIONAL RADIOLOGY

Thermal ablation with fusion imaging guidance of hepatocellular carcinoma without conspicuity on conventional or contrast-enhanced US: surrounding anatomical landmarks matter

Authors: Marco Calandri, Valeria Ruggeri, Patrizia Carucci, Stefano Mirabella, Andrea Veltri, Paolo Fonio, Carlo Gazzera

Published in: La radiologia medica | Issue 10/2019

Login to get access

Abstract

Aim

Evaluating clinical and technical factors affecting thermal ablation of B-Mode/CEUS inconspicuous HCC nodules, relying only on fusion imaging (FI) performed under conscious sedation and using previously acquired CT or MR.

Materials and methods

Among 367 HCC nodules treated in the study period, data of 37 B-mode/CEUS undetectable HCC nodules treated with FI-guided ablation were extracted from our prospectively collected institutional database. Analyzed variables included patients’ sex, age, cirrhosis etiology, Child–Pugh status, size of the lesion, liver segment, subcapsular or central liver site, type of imaging used for fusion (MR/CT), and the presence of surrounding anatomical landmarks (SAL) < 3 cm from the index lesion.

Results

The primary efficacy was 59.4% (22/37 nodules); nine lesions (24.3%) were partially ablated (PA), six lesions (16.7%) were mistargeted (MA). Eight nodules were retreated with a CA obtained in all cases (100% CA, secondary efficacy in 30/37—81.1%). LTP was observed in 2/30 cases (6.7%). Two minor complications were registered (Clavien–Dindo, Grade1, CIRSE Classification Grade 2). SAL were related to a better ablation outcome (37.5% vs 84.6% p = 0.01). No differences were observed between CA group and PA–MA group in terms of lesion size (15.4 mm vs 14.9 mm p = 0.63), liver segment (p = 0.58), subcapsular or central liver site (8/22 36% vs 4/15 26.7% p = 0.84), and imaging (MR vs CT, p = 0.72).

Conclusion

Even in the presence of potentially critical conditions (completely B-Mode/CEUS inconspicuous nodules, spontaneous breathing, and previously acquired CT or MRI), FI-only guidance is safe and allows having good primary, secondary efficacy and LTP rates. The outcome of the procedure is heavily affected by the presence of SAL.
Literature
1.
go back to reference Choi D et al (2007) Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17(3):684–692CrossRef Choi D et al (2007) Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17(3):684–692CrossRef
2.
go back to reference Livraghi T et al (2007) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 47(1):82–89CrossRef Livraghi T et al (2007) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 47(1):82–89CrossRef
3.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRef
4.
go back to reference Rhim H, Lee MH, Kim Y, Choi D, Lee WJ, Lim HK (2008) Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. Am J Roentgenol 190(5):1324–1330CrossRef Rhim H, Lee MH, Kim Y, Choi D, Lee WJ, Lim HK (2008) Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. Am J Roentgenol 190(5):1324–1330CrossRef
5.
go back to reference Samanci C et al (2016) Magnetic resonance imaging in diagnosis and monitoring of hepatocellular carcinoma in liver transplantation: a comprehensive review. Ann Transplant 21:68–76CrossRef Samanci C et al (2016) Magnetic resonance imaging in diagnosis and monitoring of hepatocellular carcinoma in liver transplantation: a comprehensive review. Ann Transplant 21:68–76CrossRef
6.
go back to reference Park HJ, Lee JM, Park SB, Lee JB, Jeong YK, Yoon JH (2016) Comparison of knowledge-based iterative model reconstruction and hybrid reconstruction techniques for liver CT evaluation of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr 40(6):863–871CrossRef Park HJ, Lee JM, Park SB, Lee JB, Jeong YK, Yoon JH (2016) Comparison of knowledge-based iterative model reconstruction and hybrid reconstruction techniques for liver CT evaluation of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr 40(6):863–871CrossRef
7.
go back to reference Kim PN et al (2012) Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility. J Vasc Interv Radiol 23(5):627–634CrossRef Kim PN et al (2012) Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility. J Vasc Interv Radiol 23(5):627–634CrossRef
8.
go back to reference Lee MW et al (2010) Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection. Am J Roentgenol 194(5):W396–W400CrossRef Lee MW et al (2010) Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection. Am J Roentgenol 194(5):W396–W400CrossRef
9.
go back to reference Kim J-E et al (2011) Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance. Eur J Radiol 79(2):e80–e84CrossRef Kim J-E et al (2011) Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance. Eur J Radiol 79(2):e80–e84CrossRef
10.
go back to reference Jo PC, Jang H-J, Burns PN, Burak KW, Kim TK, Wilson SR (2017) Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: How I do it. Radiology 282(2):317–331CrossRef Jo PC, Jang H-J, Burns PN, Burak KW, Kim TK, Wilson SR (2017) Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: How I do it. Radiology 282(2):317–331CrossRef
11.
go back to reference Lee MW (2014) Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention. Ultrasonography 33(4):227–239CrossRef Lee MW (2014) Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention. Ultrasonography 33(4):227–239CrossRef
12.
go back to reference Abi-Jaoudeh N et al (2012) Multimodality image fusion guided procedures: technique, accuracy, and applications. Cardiovasc Intervent Radiol 35(5):986–998CrossRef Abi-Jaoudeh N et al (2012) Multimodality image fusion guided procedures: technique, accuracy, and applications. Cardiovasc Intervent Radiol 35(5):986–998CrossRef
13.
go back to reference Lee MW et al (2012) Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. Am J Roentgenol 198(6):1438–1444CrossRef Lee MW et al (2012) Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. Am J Roentgenol 198(6):1438–1444CrossRef
14.
go back to reference Ewertsen C, Săftoiu A, Gruionu LG, Karstrup S, Nielsen MB (2013) Real-time image fusion involving diagnostic ultrasound. Am J Roentgenol 200(3):W249–W255CrossRef Ewertsen C, Săftoiu A, Gruionu LG, Karstrup S, Nielsen MB (2013) Real-time image fusion involving diagnostic ultrasound. Am J Roentgenol 200(3):W249–W255CrossRef
15.
go back to reference Dong Y, Wang W-P, Mao F, Ji Z-B, Huang B-J (2016) Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound: hepatocellular carcinoma imaging fusion. J Gastroenterol Hepatol 31(4):822–828CrossRef Dong Y, Wang W-P, Mao F, Ji Z-B, Huang B-J (2016) Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound: hepatocellular carcinoma imaging fusion. J Gastroenterol Hepatol 31(4):822–828CrossRef
16.
go back to reference Ewertsen C, Săftoiu A, Gruionu LG, Karstrup S, Nielsen MB (2013) Real-time image fusion involving diagnostic ultrasound. Am J Roentgenol 200(3):W249–W255CrossRef Ewertsen C, Săftoiu A, Gruionu LG, Karstrup S, Nielsen MB (2013) Real-time image fusion involving diagnostic ultrasound. Am J Roentgenol 200(3):W249–W255CrossRef
17.
go back to reference Lee MW (2014) Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention. Ultrasonography 33(4):227–239CrossRef Lee MW (2014) Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention. Ultrasonography 33(4):227–239CrossRef
18.
go back to reference Ahmed M et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology 273(1):241–260CrossRef Ahmed M et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology 273(1):241–260CrossRef
19.
go back to reference Mauri G et al (2018) Real-time US-18FDG-PET/CT image fusion for guidance of thermal ablation of 18FDG-PET-positive liver metastases: the added value of contrast enhancement. Cardiovasc Intervent Radiol 42:60–68CrossRef Mauri G et al (2018) Real-time US-18FDG-PET/CT image fusion for guidance of thermal ablation of 18FDG-PET-positive liver metastases: the added value of contrast enhancement. Cardiovasc Intervent Radiol 42:60–68CrossRef
20.
go back to reference Veltri A, Sacchetto P, Tosetti I, Pagano E, Fava C, Gandini G (2008) Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 31(5):948–956CrossRef Veltri A, Sacchetto P, Tosetti I, Pagano E, Fava C, Gandini G (2008) Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 31(5):948–956CrossRef
21.
go back to reference Mauri G et al (2015) Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol 38(1):143–151CrossRef Mauri G et al (2015) Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol 38(1):143–151CrossRef
22.
go back to reference Makino Y et al (2013) Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography. Oncology 84(s1):44–50CrossRef Makino Y et al (2013) Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography. Oncology 84(s1):44–50CrossRef
23.
go back to reference Min JH et al (2014) Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US. Clin Mol Hepatol 20(1):61CrossRef Min JH et al (2014) Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US. Clin Mol Hepatol 20(1):61CrossRef
24.
go back to reference Song KD, Lee MW, Rhim H, Cha DI, Chong Y, Lim HK (2013) Fusion imaging—guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound. Am J Roentgenol 201(5):1141–1147CrossRef Song KD, Lee MW, Rhim H, Cha DI, Chong Y, Lim HK (2013) Fusion imaging—guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound. Am J Roentgenol 201(5):1141–1147CrossRef
25.
go back to reference Minami T et al (2014) Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Oncology 87(s1):55–62CrossRef Minami T et al (2014) Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Oncology 87(s1):55–62CrossRef
26.
go back to reference Ahn SJ et al (2017) Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol 66(2):347–354CrossRef Ahn SJ et al (2017) Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol 66(2):347–354CrossRef
27.
go back to reference Hakime A, Yevich S, Tselikas L, Deschamps F, Petrover D, De Baere T (2017) Percutaneous thermal ablation with ultrasound guidance. Fusion imaging guidance to improve conspicuity of liver metastasis. Cardiovasc Intervent Radiol 40(5):721–727CrossRef Hakime A, Yevich S, Tselikas L, Deschamps F, Petrover D, De Baere T (2017) Percutaneous thermal ablation with ultrasound guidance. Fusion imaging guidance to improve conspicuity of liver metastasis. Cardiovasc Intervent Radiol 40(5):721–727CrossRef
28.
go back to reference Brunello F et al (2008) Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 43(6):727–735CrossRef Brunello F et al (2008) Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 43(6):727–735CrossRef
Metadata
Title
Thermal ablation with fusion imaging guidance of hepatocellular carcinoma without conspicuity on conventional or contrast-enhanced US: surrounding anatomical landmarks matter
Authors
Marco Calandri
Valeria Ruggeri
Patrizia Carucci
Stefano Mirabella
Andrea Veltri
Paolo Fonio
Carlo Gazzera
Publication date
01-10-2019
Publisher
Springer Milan
Published in
La radiologia medica / Issue 10/2019
Print ISSN: 0033-8362
Electronic ISSN: 1826-6983
DOI
https://doi.org/10.1007/s11547-019-01057-1

Other articles of this Issue 10/2019

La radiologia medica 10/2019 Go to the issue